Showing results (381-390 of 590) with videos related to
Sort By:
Pageof 59
Annals of Surgical Oncology|June 23, 2009
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysisAlfredo A Santillan, Keith A Delman, Georgia M Beasley, et al.Practical Radiation Oncology|March 12, 2022
Outcomes After Sphincter-Sparing Local Therapy for Anorectal Melanoma: 1989 to 2020Devarati Mitra, Pallavi Krishna Rao, Priyadharsini Nagarajan, et al.Cancer|November 2, 2002
Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrencesEugene Huang, Thomas A Buchholz, Funda Meric, et al.Archives of Surgery (Chicago, Ill. : 1960)|July 23, 2008
Effect of multiple-nodal basin drainage on cutaneous melanomaAndrea C Federico, Anees B Chagpar, Merrick I Ross, et al.Cancer|June 22, 2005
Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrenceJeannie Shen, Kelly K Hunt, Nadeem Q Mirza, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 8, 2020
Prognostic significance of acral lentiginous histologic type in T1 melanomaHaider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, et al.Pharmacogenetics and Genomics|March 16, 2006
Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanomaChunying Li, Derek Larson, Zhengdong Zhang, et al.Annals of Surgical Oncology|February 8, 2006
Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsyLaura A Lambert, Gregory D Ayers, Rosa F Hwang, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|May 1, 1996
Phase Ia/Ib trial of anti-GD2 chimeric monoclonal antibody 14.18 (ch14.18) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in metastatic melanomaJ L Murray, E S Kleinerman, S F Jia, et al.Annals of Surgery|September 1, 1996
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and youngerC M Balch, S J Soong, A A Bartolucci, et al.Pageof 59